Select Language

T4 RNA Ligase 1

Product Inquiry

English Name	Research Code	Highest Development Stage	Company	First Brand Name	First Approved Country	First Indication	First Approved Company	First Approved Date	Indication	Clinical Trial
Itolizumab	T-1-hT; EQ-001; T-1-h; h-T1; Bmab-600	Approved	Biocon Ltd, Center Of Molecular Immunology, Biotech Pharmaceuticals Co Ltd	Alzumab	India	Plaque psoriasis	Biocon Ltd	2013-01-01	Dermatomyositis; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Coronavirus Disease 2019 (COVID-19); Lupus Nephritis; Respiratory Distress Syndrome, Adult; Psoriasis; Asthma; Plaque psoriasis	Details